Bevacizumab, an anti-vascular endothelial growth factor antibody, inhibits osteoarthritis
Crossref DOI link: https://doi.org/10.1186/s13075-014-0427-y
Published Online: 2014-09-18
Published Print: 2014-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nagai, Toshihiro
Sato, Masato
Kobayashi, Miyuki
Yokoyama, Munetaka
Tani, Yoshiki
Mochida, Joji
License valid from 2014-09-18